Related Experiment Video

Updated: Aug 18, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute

M F Johan1, D T Bowen, M E Frew

  • 1Academic Unit of Haematology, Division of Genomic Medicine, Henry Wellcome Laboratories for Medical Research, Sheffield, UK.

British Journal of Haematology
|April 2, 2005
PubMed

Insights

Aberrant methylation of RASSF1A, SHP-1, and SOCS-1 genes was investigated in myeloid malignancies. Methylation defects in these negative regulators of RTK/RAS signaling were found in myelodysplastic syndromes and acute myeloid leukemia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Receptor tyrosine kinase (RTK/RAS) signaling pathways drive proliferation in myeloid malignancies.
  • Negative regulators like RASSF1A, SHP-1, and SOCS-1 are crucial for controlling RTK/RAS signaling.
  • Their role in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) remains under-explored.

Purpose of the Study:

  • To investigate aberrant promoter methylation of RASSF1A, SHP-1, and SOCS-1 in MDS and AML.
  • To determine the potential role of these epigenetic alterations in the pathogenesis of myeloid malignancies.

Main Methods:

  • Methylation-specific polymerase chain reaction (MS-PCR) was utilized.
  • Analysis included patients with MDS (n=107), AML (n=154), and juvenile myelomonocytic leukemia (JMML, n=5), plus 15 normal controls.
  • Primers targeted promoter regions of RASSF1A, SHP-1, and SOCS-1, with additional analysis of SOCS-1 exon 2.

Main Results:

  • RASSF1A methylation was observed in 9% of MDS and 20% of JMML cases, but not in AML.
  • SHP-1 methylation was found in 11% of AML cases, absent in MDS and JMML.
  • SOCS-1 promoter methylation occurred in 11% of MDS cases, absent in JMML and AML. RAS mutations and RASSF1A/SOCS-1 methylation were mutually exclusive.
  • SOCS-1 exon 2 methylation was detected in normal samples and lacked correlation with promoter methylation, suggesting limited pathogenic relevance.

Conclusions:

  • Aberrant promoter methylation of RASSF1A, SHP-1, and SOCS-1 occurs in myeloid malignancies.
  • Approximately 30% of MDS cases exhibit defects in RTK/RAS pathway negative regulation due to these epigenetic changes.
  • SOCS-1 exon 2 methylation is unlikely to be pathogenetically significant.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...